MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

96 hedge funds and large institutions have $279M invested in Marinus Pharmaceuticals, Inc in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+23
Holders Change %
+31.51%
% of All Funds
2.2%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
33
Increased
23
Reduced
19
Closed
10
Calls
$18.3M
Puts
$8.28M
Net Calls
+$10M
Net Calls Change
+$7.93M

Top Buyers

1
PHS
PFM Health Sciences
California
$17.7M
2
CS
Credit Suisse
Switzerland
$10.3M
3
Goldman Sachs
Goldman Sachs
New York
$5.03M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$4.09M
5
TCM
Tekla Capital Management
Massachusetts
$3.36M

Top Sellers

1
GPCM
Granite Point Capital Management
Massachusetts
$10.6M
2
Jennison Associates
Jennison Associates
New York
$19M
3
MWNA
Marshall Wace North America
New York
$0
4
CAM
Cormorant Asset Management
Massachusetts
$3M
5
HT
HAP Trading
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GCP
101
GSA Capital Partners
United Kingdom
– -$141K -4,975 Closed
FAM
102
Fred Alger Management
New York
– -$127K -4,500 Closed
DekaBank Deutsche Girozentrale
103
DekaBank Deutsche Girozentrale
Germany
– -$120K -4,250 Closed
TI
104
Trexquant Investment
Connecticut
– -$102K -3,616 Closed
SO
105
STRS Ohio
Ohio
– -$75K -2,675 Closed
PIA
106
Piedmont Investment Advisors
North Carolina
– -$4K -158 Closed
1 2 3 4
5